|
|
|
30.01.26 - 00:33
|
Apple Rises After Shocking China Sales Beat Offsets US Revenue Miss (ZeroHedge)
|
|
|
Apple Rises After Shocking China Sales Beat Offsets US Revenue Miss
Ahead of today's AAPL earnings report, we've had a very mixed picture from Mag 7 earnings so far: first, there was Microsoft, which crashed after its capex forecast unexpectedly jumped, then there was META, which soared after its capex forecast unexpectedly jumped (only in this case the company made up for it by pretending its ad revenue will also increase almost dollar for dollar with the new capex), and then there was TESLA which first dropped, then jumped, then dropped as the market digested the company's complete conversion from an auto company (now without the S and X models) and into a robotaxi "story" stock. As such, many are looking to AAPL to break the tie when it reports at 3pm today.
But before we look at the numbers, here's what Wall Street is expecting:
Revenue estimate $138.4 billion
Products revenue estimate $107.69 billion
Mac revenue estimate $9.13 billion
IPad revenue estimate $8.18 billion...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
29.01.26 - 20:12
|
AstraZeneca to invest £11bn in China after rowing back on UK expansion (The Guardian)
|
|
|
Move comes after Britain's biggest drugmaker's dispute with government over drug pricingBritain's biggest drugmaker AstraZeneca is to invest $15bn (£11bn) in China, it announced during Keir Starmer's visit to the country, just months after cooling on plans for expansion in the UK.The Cambridge-based company said it would spend the money by 2030 to expand medicines manufacturing and research and development in China, where it already has a big presence. It includes the construction of a $2.5bn research hub in Beijing, which was announced last March. Continue reading......
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|